Park National Corp OH Reduces Holdings in Baxter International Inc. $BAX

Park National Corp OH lowered its stake in Baxter International Inc. (NYSE:BAX) by 92.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 18,840 shares of the medical instruments supplier’s stock after selling 246,802 shares during the quarter. Park National Corp OH’s holdings in Baxter International were worth $360,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the stock. CoreFirst Bank & Trust acquired a new position in shares of Baxter International in the second quarter worth $27,000. Imprint Wealth LLC purchased a new stake in shares of Baxter International in the third quarter valued at $27,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Baxter International during the second quarter valued at $40,000. MUFG Securities EMEA plc purchased a new stake in Baxter International during the 2nd quarter worth about $46,000. Finally, Motco increased its position in Baxter International by 374.7% during the 3rd quarter. Motco now owns 3,071 shares of the medical instruments supplier’s stock worth $70,000 after purchasing an additional 2,424 shares in the last quarter. Institutional investors and hedge funds own 90.19% of the company’s stock.

Analyst Ratings Changes

BAX has been the subject of several analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Baxter International in a research note on Wednesday, January 21st. The Goldman Sachs Group lowered their price target on shares of Baxter International from $21.00 to $17.00 and set a “neutral” rating for the company in a report on Friday, February 13th. Citigroup cut their price objective on shares of Baxter International from $21.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, March 11th. Jefferies Financial Group reduced their price objective on shares of Baxter International from $21.00 to $19.00 and set a “hold” rating on the stock in a research note on Friday, February 13th. Finally, Barclays decreased their target price on shares of Baxter International from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Two analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Baxter International presently has an average rating of “Hold” and a consensus price target of $19.90.

Baxter International Trading Down 2.8%

NYSE BAX opened at $16.20 on Friday. The firm has a market capitalization of $8.34 billion, a price-to-earnings ratio of -8.75, a PEG ratio of 1.17 and a beta of 0.58. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.56 and a current ratio of 2.31. Baxter International Inc. has a one year low of $16.08 and a one year high of $34.51. The company’s 50 day moving average price is $19.66 and its 200 day moving average price is $20.37.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Thursday, February 12th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by ($0.09). Baxter International had a positive return on equity of 16.95% and a negative net margin of 8.51%.The business had revenue of $2.97 billion for the quarter, compared to analysts’ expectations of $2.82 billion. During the same quarter in the prior year, the firm earned $0.58 earnings per share. Baxter International’s quarterly revenue was up 8.0% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.850-2.050 EPS. On average, sell-side analysts predict that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Friday, February 27th will be issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, February 27th. Baxter International’s dividend payout ratio is currently -2.16%.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.